Jennifer Arnold

6.7k total citations
92 papers, 3.1k citations indexed

About

Jennifer Arnold is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Jennifer Arnold has authored 92 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Ophthalmology, 64 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Epidemiology. Recurrent topics in Jennifer Arnold's work include Retinal Diseases and Treatments (75 papers), Retinal Imaging and Analysis (64 papers) and Retinal and Optic Conditions (46 papers). Jennifer Arnold is often cited by papers focused on Retinal Diseases and Treatments (75 papers), Retinal Imaging and Analysis (64 papers) and Retinal and Optic Conditions (46 papers). Jennifer Arnold collaborates with scholars based in Australia, Switzerland and France. Jennifer Arnold's co-authors include S H Sarks, J P Sarks, Murray C. Killingsworth, Mark C. Gillies, Robyn H. Guymer, Daniel Barthelmes, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex and Nigel Morlet and has published in prestigious journals such as Environmental Science & Technology, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Jennifer Arnold

90 papers receiving 3.0k citations

Peers

Jennifer Arnold
Michael A. Callahan United States
Anselm Hennis United States
Sarah L. Hale United States
Julie Crewe Australia
Michael A. Callahan United States
Jennifer Arnold
Citations per year, relative to Jennifer Arnold Jennifer Arnold (= 1×) peers Michael A. Callahan

Countries citing papers authored by Jennifer Arnold

Since Specialization
Citations

This map shows the geographic impact of Jennifer Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Arnold more than expected).

Fields of papers citing papers by Jennifer Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Arnold. The network helps show where Jennifer Arnold may publish in the future.

Co-authorship network of co-authors of Jennifer Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Arnold. A scholar is included among the top collaborators of Jennifer Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Arnold. Jennifer Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zur, Dinah, Robyn H. Guymer, Jean‐François Korobelnik, et al.. (2024). Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration. British Journal of Ophthalmology. 109(3). 307–315. 3 indexed citations
2.
Yuen, Yew Sen, Jagjit S. Gilhotra, Michelle Dalton, et al.. (2023). Diabetic Macular Oedema Guidelines: An Australian Perspective. Journal of Ophthalmology. 2023(1). 6329819–6329819. 3 indexed citations
3.
Mitchell, Paul, Jennifer Arnold, Samantha Fraser‐Bell, et al.. (2023). Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study. BMJ Open Ophthalmology. 8(1). e001224–e001224. 7 indexed citations
4.
Teo, Kelvin Yi Chong, Vuong Nguyen, Vincent Daïen, et al.. (2022). Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration. Eye. 37(3). 467–473. 6 indexed citations
5.
Hunt, Adrian, Vuong Nguyen, S. Bhandari, et al.. (2022). Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF. Ophthalmology Retina. 7(4). 338–345. 6 indexed citations
6.
Grechenig, Christoph, Gregor S. Reiter, Sophie Riedl, et al.. (2021). Impact of Residual Subretinal Fluid Volumes on Treatment Outcomes in a SRF-tolerant Treat & Extend Regimen. Investigative Ophthalmology & Visual Science. 62(8). 104–104. 2 indexed citations
7.
Fraser‐Bell, Samantha, et al.. (2021). Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study. British Journal of Ophthalmology. 107(1). 72–78. 9 indexed citations
8.
Fung, Adrian T., Sebastian M. Waldstein, Orly Gal‐Or, et al.. (2020). Focal Scleral Nodule. Ophthalmology. 127(11). 1567–1577. 15 indexed citations
9.
Lek, Jia Jia, Kate Brassington, Chi D. Luu, et al.. (2016). SUBTHRESHOLD NANOSECOND LASER INTERVENTION IN INTERMEDIATE AGE-RELATED MACULAR DEGENERATION (AMD). THE LASER IN EARLY STAGES OF AGE-RELATED MACULAR DEGENERATION (LEAD) STUDY: STUDY DESIGN AND BASELINE CHARACTERISTICS. Clinical and Experimental Ophthalmology. 44. 1 indexed citations
10.
Wang, Jie Jin, George Burlutsky, Sudha Cugati, et al.. (2016). Risk of Age-related Macular Degeneration 5 Years after Cataract Surgery: Findings from a cataract surgical cohort. Investigative Ophthalmology & Visual Science. 57(12). 15–15. 3 indexed citations
11.
Gillies, Mark C., Richard Walton, Jennifer Arnold, et al.. (2016). Twelve months outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: observational study data. Investigative Ophthalmology & Visual Science. 57(12). 523–523. 1 indexed citations
12.
Arnold, Jennifer, Caroline M. Markey, Paul N. Baird, et al.. (2015). BASELINE CHARACTERISTICS OF THE FLUID STUDY PATIENTS: A RANDOMISED CLINICAL TRIAL INVESTIGATING THE NEED FOR COMPLETE RESOLUTION OF SUB-RETINAL FLUID (SRF) IN RANIBIZUMAB-TREATED PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT AND EXTEND (T&E) REGIMEN. Clinical and Experimental Ophthalmology. 43. 1 indexed citations
13.
Barthelmes, Daniel, Richard Walton, Judy M. Simpson, et al.. (2014). Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data. British Journal of Ophthalmology. 99(3). 359–364. 4 indexed citations
14.
Gillies, Mark C., Richard Walton, Jennifer Arnold, et al.. (2013). EFFICIENT CAPTURE OF HIGH-QUALITY DATA ON OUTCOMES OF TREATMENT FOR MACULAR DISEASES. Retina. 34(1). 188–195. 102 indexed citations
15.
Arnold, Jennifer, et al.. (2012). Agranulocytosis from Levamisole-Adulterated Cocaine. The Journal of the American Board of Family Medicine. 25(4). 528–530. 11 indexed citations
16.
Arnold, Jennifer, J P Sarks, Murray C. Killingsworth, Emma Kettle, & S H Sarks. (2003). Adult vitelliform macular degeneration: a clinicopathological study. Eye. 17(6). 717–726. 84 indexed citations
17.
Arnold, Jennifer, et al.. (2000). Bilateral choroidal ischaemia and serous retinal detachment in pre‐eclampsia. Clinical and Experimental Ophthalmology. 28(5). 387–390. 31 indexed citations
18.
Arnold, Jennifer, et al.. (1997). Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 235(4). 208–216. 16 indexed citations
19.
Arnold, Jennifer, et al.. (1997). Indocyanine Green Angiography of Drusen. American Journal of Ophthalmology. 124(3). 344–356. 78 indexed citations
20.
Arnold, Jennifer. (1995). Ocular manifestations of congenital rubella. Current Opinion in Ophthalmology. 6(3). 45–50. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026